Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces

Microdosing Research
  • The study found that a low dose of LSD significantly reduced the neural responses associated with processing neutral and happy faces, suggesting a nuanced influence of LSD on emotional face recognition.
  • Participants reported feeling the effects of the LSD, highlighting its physiological impact through increased ratings on measures of intoxication and changes in blood pressure without full psychedelic experiences.
  • The findings indicate potential clinical implications, suggesting that low doses of LSD could serve as biomarkers for therapeutic effects on emotional processing in the brain.

Understanding the Context of the Study

The study conducted by Haggarty and colleagues arises from a renewed interest in the therapeutic properties of psychedelic substances like LSD. While much of the research focuses on higher, hallucinogenic doses, there is a trend toward exploring lower doses that do not induce such effects but may still influence mood and cognition. Anecdotal evidence suggests that low doses of LSD can enhance well-being; however, these claims lack robust evidence from controlled studies.

Mechanisms Behind LSD’s Effects

The researchers explain that even without inducing hallucinogenic experiences, low doses of LSD could affect brain connectivity and reactivity to rewarding stimuli. They point out previous studies that have shown altered neural dynamics in reward-related and emotional processing circuits following ingestion of low doses of LSD. Factors like serotonin receptor activation, neuroplasticity, and release of specific growth factors are believed to mediate these effects.

Exploring the Impact of Emotional Faces

Emotional face stimuli are critical in studying drug effects on social and emotional processing. The authors note that traditional, higher doses of psychedelics have impaired the recognition of certain emotional expressions. They focus particularly on event-related potentials (ERPs), specific patterns of electrical activity in the brain that respond to emotional face stimuli. The study zeroes in on two ERPs: the N170, which reflects early face processing, and the P300, associated with attention and memory updates.

Study Design and Methodology

This study utilized a rigorous double-blind design involving healthy adults who received either a low dose of LSD or a placebo. During the sessions, participants engaged in an emotional oddball task while their EEG was recorded, allowing for the measurement of ERPs in response to various emotional expressions. Participants underwent a screening process to ensure they met specific health criteria, and they provided informed consent prior to participation.

Behavioral and Physiological Outcomes

Following administration, the researchers observed that LSD led to increased feelings of intoxication and elevated arterial blood pressure among participants, which were strongest around 60 to 180 minutes post-ingestion. Even at low doses, LSD produced notable psychological and physiological responses that align with its known effects, though participants did not experience the full spectrum of psychedelic experiences.

Key Findings Regarding ERPs

The results indicated that LSD significantly diminished the amplitudes of the N170 in response to neutral faces, suggesting that the drug alters how the brain processes these stimuli. Additionally, for the P300 component, LSD notably reduced responses to both neutral and happy faces while leaving responses to angry faces unchanged. The alterations in these ERPs point to LSD’s potential to modulate emotional recognition and processing circuits in the brain.

Discussion of the Findings

In their analysis, the researchers emphasize that this non-psychedelic dose of LSD impacts various aspects of brain function linked to emotional face processing. They draw comparisons to existing literature indicating that higher doses of psychedelics also affect neural responses to emotional stimuli, suggesting a continuum of effect across different dosages. This could have significant implications for understanding how psychoactive substances may influence emotional processing in therapeutic contexts.

Conclusion and Future Directions

The study concludes by proposing that the observed changes in ERP components could be relevant for future therapeutic applications of psychedelics. The authors encourage additional research to explore the effects of LSD and similar compounds on emotional processing further, as well as to investigate the potential for these neural measures to serve as indicators of therapeutic efficacy. The researchers suggest that understanding how serotonin influences emotional responses through low-dose LSD could open avenues for new psychological treatments.

See also our coverage of Inter-individual variability in neural response to low, and our explainers on James Fadiman. Read the full paper summary on Blossom.

Science

Is Microdosing Just a Placebo? What Placebo-Controlled Studies Show

Placebo-controlled studies show that microdoses measurably change the brain and body, but so far they find few consistent improvements in mood or wellbeing beyond placebo. Surveys and personal reports are far more positive, and part of that gap is explained by expectation and by participants guessing what they took. Below

JOIN OUR COMMUNITY!

 Want to stay updated about microdosing research, the latest news, tips & tricks, and more? Subscribe to our newsletter below and stay in the loop about everything microdosing!